is hims semaglutide fda approved & Hers abandons copycat weight-loss drug in face of probe The FDA announced plans to

That means just over 9 out of 10 participants who completed the trial lost at least 10% of their body weight, a threshold that carries measurable clinical significance for cardiovascular and metabolic health

Translational Andrology and Urology, 9(Suppl 2), S149-S159

Set a phone reminder if needed

Unlike standard prescription drugs, compounded medications are not reviewed or approved by the FDA, meaning the agency does not assess their safety, effectiveness, or quality before they are distributed

Moreover, not all patients with MASH are overweight or obese

Tirzepatide is a dual GIP/GLP-1 receptor agonist, sold as Mounjaro (type 2 diabetes) and Zepbound (chronic weight management)